-
Products
- Recombinant Antibodies
-
Functional Antibodies
- CDC Enhanced Antibodies
- ADCC Enhanced Antibodies
- ADCC/CDC Decreased Antibodies
- Intrabodies
- Blocking Antibodies
- Neutralizing Antibodies
- Autoantibodies
- Idiotypic Antibodies
- Agonistic Antibodies
- Epitope-Specific Antibodies
- Glyco-Engineering Antibodies
- Biparatopic Antibodies
- Vaccinal Antibodies
- Eliminating Antibodies
- pH-dependent Antibodies
- Antibody Prodrugs
- Anti-Drug Antibodies
- Antibody Formats
- AbPlus
- Research Area
- AbProcessing
- Tetramers
- Proteolytic Enzymes
- Antibody-like Scaffold Proteins
- Therapeutic Proteins
- Soluble T Cell Receptors
- Antibody-Stable Cell Pools
-
Services
- High Throughput Antibody Production
-
Custom Antibody Production & QC
- Prokaryotic System based Antibody Production & QC
- Eukaryotic System based Antibody Production & QC
- Antibody Fragment Production & QC
- Antibody Production & QC with Cell-Free Systems
- Light-based Antibody Purification
- Functional Antibody Production & QC
- IgA Engineering & Production
- Rare Species derived Antibody Production & QC
- Engineered Antibody Production & QC
- Antibody Derivative Development
- Bispecific Antibody Development
- Antibody-Drug Conjugate Development
- Glycoprotein Glycosylation Analysis
- BCR Production & QC
- Soluble TCR Production & QC
- OmicsMab™ Proteome Scale Antibody Discovery
- Antibody based Active Targeting System
- CDMO Solutions
- Biosimilar
-
Research Area
-
Cancer Biomarkers
- Bladder Cancer Biomarkers
- Breast Cancer Biomarkers
- Colorectal Cancer Biomarkers
- Gastric Cancer Biomarkers
- Glioma Biomarkers
- Head and Neck Cancer Biomarkers
- Liver Cancer Biomarkers
- Lung Cancer Biomarkers
- Medulloblastoma Biomarkers
- Melanoma Biomarkers
- Osteosarcoma Biomarkers
- Ovarian Cancer Biomarkers
- Pancreatic Cancer Biomarkers
- Prostate Cancer Biomarkers
- Cancer Immunology
- Oncoproteins
- Signal Transduction in Cancer
- Cell Cycle
- Cell Metabolism
- Apoptosis
- Autophagy
-
Cancer Biomarkers
- Supports
- Company
